[1]
Mayer, S.V.; Tesh, R.B.; Vasilakis, N. The emergence of arthropod-borne viral diseases: A global prospective on dengue, chikungunya and zika fevers. Acta Trop., 2017, 166, 155-163. [http://dx.doi.org/10.1016/j.actatropica.2016.11.020]. [PMID: 27876643].
[3]
Medlock, J.M.; Avenell, D.; Barrass, I.; Leach, S. Analysis of the potential for survival and seasonal activity of Aedes albopictus (Diptera: Culicidae) in the United Kingdom. J. Vector Ecol, 2006, 31(2), 292-304. [http://dx.doi.org/10.3376/1081- 1710(2006)31[292:AOTPFS]2.0.CO;2] [PMID: 17249347]
[4]
Weaver, S.C.; Reisen, W.K. Present and future arboviral threats. Antiviral Res., 2010, 85(2), 328-345. [http://dx.doi.org/10.1016/j.antiviral.2009.10.008]. [PMID: 19857523].
[5]
Medlock, J.M.; Leach, S.A. Effect of climate change on vector-borne disease risk in the UK. Lancet Infect. Dis., 2015, 15(6), 721-730. [http://dx.doi.org/10.1016/S1473-3099(15)70091-5]. [PMID: 25808458].
[6]
Negev, M.; Paz, S.; Clermont, A.; Pri-Or, N.G.; Shalom, U.; Yeger, T.; Green, M.S. Impacts of climate change on vector borne diseases in the Mediterranean basin-implications for preparedness and adaptation policy. Int. J. Environ. Res. Public Health, 2015, 12(6), 6745-6770. [http://dx.doi.org/10.3390/ijerph120606745]. [PMID: 26084000].
[7]
Brand, S.P.C.; Keeling, M.J. The impact of temperature changes on vector-borne disease transmission: Culicoides midges and bluetongue virus. J. R. Soc. Interface, 2017, 14(128)20160481 [http://dx.doi.org/10.1098/rsif.2016.0481]. [PMID: 28298609].
[8]
Caminade, C.; McIntyre, K.M.; Jones, A.E. Impact of recent and future climate change on vector-borne diseases. Ann. N. Y. Acad. Sci., 2019, 1436(1), 157-173. [DOI: 10.1111/nyas.13950. Epub 2018]. [PMID: 30120891].
[9]
Vora, N. Impact of anthropogenic environmental alterations on vector-borne diseases. Medscape J. Med., 2008, 10(10), 238. [PMID: 19099032].
[10]
Reiter, P. Climate change and mosquito-borne disease. Environ. Health Perspect., 2001, 109(Suppl. 1), 141-161. [PMID: 11250812].
[11]
Lindsay, S.W.; Birley, M.H. Climate change and malaria transmission. Ann. Trop. Med. Parasitol., 1996, 90(6), 573-588. [http://dx.doi.org/10.1080/00034983.1996.11813087]. [PMID: 9039269].
[12]
Ogden, N.H.; Lindsay, L.R. Effect of climate and change on vectors and vector-borne diseases: Ticks are different. Trends Parasitol., 2016, 32(8), 646-656. [http://dx.doi.org/10.1016/j.pt.2016.04.015]. [PMID: 27260548].
[13]
Carpenter, S.; Wilson, A.; Barber, J.; Veronesi, E.; Mellor, P.; Venter, G.; Gubbins, S. Temperature dependence of the extrinsic incubation period of orbiviruses in Culicoides biting midges. PLoS One, 2011, 6(11)e27987 [http://dx.doi.org/10.1371/journal.pone.0027987]. [PMID: 22125649].
[14]
Schwan, T.G.; Piesman, J. Vector interactions and molecular adaptations of lyme disease and relapsing fever spirochetes associated with transmission by ticks. Emerg. Infect. Dis., 2002, 8(2), 115-121. [http://dx.doi.org/10.3201/eid0802.010198]. [PMID: 11897061].
[15]
Githeko, A.K.; Lindsay, S.W.; Confalonieri, U.E.; Patz, J.A. Climate change and vector-borne diseases: a regional analysis. Bull. World Health Organ., 2000, 78(9), 1136-1147. [PMID: 11019462].
[16]
Liu, Z.; Zhang, Z.; Lai, Z.; Zhou, T.; Jia, Z.; Gu, J.; Wu, K.; Chen, X.G. Temperature increase enhances Aedes albopictus competence to transmit dengue virus. Front. Microbiol., 2017, 8, 2337. [http://dx.doi.org/10.3389/fmicb.2017.02337]. [PMID: 29250045].
[17]
Mulwa, F.; Lutomiah, J.; Chepkorir, E.; Okello, S.; Eyase, F.; Tigoi, C.; Kahato, M.; Sang, R. Vector competence of Aedes bromeliae and Aedes vitattus mosquito populations from Kenya for chikungunya virus. PLoS Negl. Trop. Dis., 2018, 12(10)e0006746 [http://dx.doi.org/10.1371/journal.pntd.0006746]. [PMID: 30321181].
[18]
Benelli, G. Research in mosquito control: Current challenges for a brighter future. Parasitol. Res., 2015, 114(8), 2801-2805. [http://dx.doi.org/10.1007/s00436-015-4586-9]. [PMID: 26093499].
[19]
Benelli, G. Plant-borne ovicides in the fight against mosquito vectors of medical and veterinary importance: a systematic review. Parasitol. Res., 2015, 114(9), 3201-3212. [http://dx.doi.org/10.1007/s00436-015-4656-z]. [PMID: 26239801].
[20]
Fusco, D.N.; Chung, R.T. Review of current dengue treatment and therapeutics in development. J. Bioanal. Biomed., 2014, (S8), 002.
[21]
Vasantha-Srinivasan, P.; Senthil-Nathan, S.; Ponsankar, A.; Thanigaivel, A.; Edwin, E.S.; Selin-Rani, S.; Chellappandian, M.; Pradeepa, V.; Lija-Escaline, J.; Kalaivani, K.; Hunter, W.B.; Duraipandiyan, V.; Al-Dhabi, N.A. Comparative analysis of mosquito (Diptera: Culicidae: Aedes aegypti Liston) responses to the insecticide Temephos and plant derived essential oil derived from Piper betle L. Ecotoxicol. Environ. Saf., 2017, 139, 439-446. [http://dx.doi.org/10.1016/j.ecoenv.2017.01.026]. [PMID: 28213320].
[22]
Simmons, C.P.; Farrar, J.J.; Nguyen, V.; Wills, B. Dengue. N. Engl. J. Med., 2012, 366(15), 1423-1432. [http://dx.doi.org/10.1056/NEJMra1110265]. [PMID: 22494122].
[23]
Edwin, E.S.; Vasantha-Srinivasan, P.; Senthil-Nathan, S.; Thanigaivel, A.; Ponsankar, A.; Pradeepa, V.; Selin-Rani, S.; Kalaivani, K.; Hunter, W.B.; Abdel-Megeed, A.; Duraipandiyan, V.; Al-Dhabi, N.A. Anti-dengue efficacy of bioactive andrographolide from Andrographis paniculata (Lamiales: Acanthaceae) against the primary dengue vector Aedes aegypti (Diptera: Culicidae). Acta Trop., 2016, 163, 167-178. [http://dx.doi.org/10.1016/j.actatropica.2016.07.009]. [PMID: 27443607].
[24]
Fitzpatrick, C.; Haines, A.; Bangert, M.; Farlow, A.; Hemingway, J.; Velayudhan, R. An economic evaluation of vector control in the age of a dengue vaccine. PLoS Negl. Trop. Dis., 2017, 11(8)e0005785 [http://dx.doi.org/10.1371/journal.pntd.0005785]. [PMID: 28806786].
[25]
Xiao, J.P.; He, J.F.; Deng, A.P.; Lin, H.L.; Song, T.; Peng, Z.Q.; Wu, X.C.; Liu, T.; Li, Z.H.; Rutherford, S.; Zeng, W.L.; Li, X.; Ma, W.J.; Zhang, Y.H. Characterizing a large outbreak of dengue fever in Guangdong Province, China. Infect. Dis. Poverty, 2016, 5, 44. [http://dx.doi.org/10.1186/s40249-016-0131-z]. [PMID: 27142081].
[26]
Thisyakorn, U.; Thisyakorn, C. Latest developments and future directions in dengue vaccines. Ther. Adv. Vaccines, 2014, 2(1), 3-9. [http://dx.doi.org/10.1177/2051013613507862]. [PMID: 24757522].
[27]
Capeding, M.R.; Tran, N.H.; Hadinegoro, S.R.; Ismail, H.I.; Chotpitayasunondh, T.; Chua, M.N.; Luong, C.Q.; Rusmil, K.; Wirawan, D.N.; Nallusamy, R.; Pitisuttithum, P.; Thisyakorn, U.; Yoon, I.K.; van der Vliet, D.; Langevin, E.; Laot, T.; Hutagalung, Y.; Frago, C.; Boaz, M.; Wartel, T.A.; Tornieporth, N.G.; Saville, M.; Bouckenooghe, A. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: A phase 3, randomised, observer-masked, placebo-controlled trial. Lancet, 2014, 384(9951), 1358-1365. [http://dx.doi.org/10.1016/S0140-6736(14)61060-6]. [PMID: 25018116].
[28]
Larsen, C.P.; Whitehead, S.S.; Durbin, A.P. Dengue human infection models to advance dengue vaccine development. Vaccine, 2015, 33(50), 7075-7082. [http://dx.doi.org/10.1016/j.vaccine.2015.09.052]. [PMID: 26424605].
[29]
Guerra, C.A.; Snow, R.W.; Hay, S.I. Mapping the global extent of malaria in 2005. Trends Parasitol., 2006, 22(8), 353-358. [http://dx.doi.org/10.1016/j.pt.2006.06.006]. [PMID: 16798089].
[31]
Dhangadamajhi, G.; Kar, S.K.; Ranjit, M. The survival strategies of malaria parasite in the red blood cell and host cell polymorphisms. Malar. Res. Treat., 2010.2010973094 [http://dx.doi.org/10.4061/2010/973094]. [PMID: 22332025].
[32]
Isah, M.B.; Ibrahim, M.A. The role of antioxidants treatment on the pathogenesis of malarial infections: A review. Parasitol. Res., 2014, 113(3), 801-809. [http://dx.doi.org/10.1007/s00436-014-3804-1]. [PMID: 24525759].
[33]
White, N.J. Antimalarial drug resistance. J. Clin. Invest., 2004, 113(8), 1084-1092. [http://dx.doi.org/10.1172/JCI21682]. [PMID: 15085184].
[34]
Fidock, D.A.; Nomura, T.; Talley, A.K.; Cooper, R.A.; Dzekunov, S.M.; Ferdig, M.T.; Ursos, L.M.; Sidhu, A.B.; Naudé, B.; Deitsch, K.W.; Su, X.Z.; Wootton, J.C.; Roepe, P.D.; Wellems, T.E. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell, 2000, 6(4), 861-871. [http://dx.doi.org/10.1016/S1097-2765(05)00077-8]. [PMID: 11090624].
[35]
Lehane, A.M.; McDevitt, C.A.; Kirk, K.; Fidock, D.A. Degrees of chloroquine resistance in Plasmodium - is the redox system involved? Int. J. Parasitol. Drugs Drug Resist., 2012, 2, 47-57. [http://dx.doi.org/10.1016/j.ijpddr.2011.11.001]. [PMID: 22773965].
[36]
Wells, T.N.; Hooft van Huijsduijnen, R.; Van Voorhis, W.C. Malaria medicines: a glass half full? Nat. Rev. Drug Discov., 2015, 14(6), 424-442. [http://dx.doi.org/10.1038/nrd4573]. [PMID: 26000721].
[37]
Cui, L.; Trongnipatt, N.; Sattabongkot, J.; Udomsangpetch, R. Culture of exoerythrocytic stages of the malaria parasites Plasmodium falciparum and Plasmodium vivax. Methods Mol. Biol., 2009, 470, 263-273. [http://dx.doi.org/10.1007/978-1-59745-204-5_18]. [PMID: 19089388].
[38]
Price, R.N. Artemisinin drugs: Novel antimalarial agents. Expert Opin. Investig. Drugs, 2000, 9(8), 1815-1827. [http://dx.doi.org/10.1517/13543784.9.8.1815]. [PMID: 11060779].
[39]
Shanks, G.D.; Möhrle, J.J. Treating malaria: New drugs for a new era. Lancet Infect. Dis., 2017, 17(12), 1223-1224. [http://dx.doi.org/10.1016/S1473-3099(17)30475-9]. [PMID: 28916444].
[40]
Coelho, C.H.; Doritchamou, J.Y.A.; Zaidi, I.; Duffy, P.E. Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium. NPJ Vaccines, 2017, 2, 34. [http://dx.doi.org/10.1038/s41541-017-0035-3]. [PMID: 29522056].
[41]
Ouattara, A.; Laurens, M.B. Vaccines against malaria. Clin. Infect. Dis., 2015, 60(6), 930-936. [http://dx.doi.org/10.1093/cid/ciu954]. [PMID: 25452593].
[42]
Hoffman, S.L.; Vekemans, J.; Richie, T.L.; Duffy, P.E. The march toward malaria vaccines. Vaccine, 2015, 33(Suppl. 4), D13-D23. [http://dx.doi.org/10.1016/j.vaccine.2015.07.091]. [PMID: 26324116].
[43]
Schwameis, M.; Buchtele, N.; Wadowski, P.P.; Schoergenhofer, C.; Jilma, B. Chikungunya vaccines in development. Hum. Vaccin. Immunother., 2016, 12(3), 716-731. [http://dx.doi.org/10.1080/21645515.2015.1101197]. [PMID: 26554522].
[44]
Robin, S.; Ramful, D.; Zettor, J.; Benhamou, L.; Jaffar-Bandjee, M.C.; Rivière, J.P.; Marichy, J.; Ezzedine, K.; Alessandri, J.L. Severe bullous skin lesions associated with Chikungunya virus infection in small infants. Eur. J. Pediatr., 2010, 169(1), 67-72. [http://dx.doi.org/10.1007/s00431-009-0986-0]. [PMID: 19401826].
[45]
Schwartz, O.; Albert, M.L. Biology and pathogenesis of chikungunya virus. Nat. Rev. Microbiol., 2010, 8(7), 491-500. [http://dx.doi.org/10.1038/nrmicro2368]. [PMID: 20551973].
[46]
Bordi, L.; Carletti, F.; Castilletti, C.; Chiappini, R.; Sambri, V.; Cavrini, F.; Ippolito, G.; Di Caro, A.; Capobianchi, M.R. Presence of the A226V mutation in autochthonous and imported Italian chikungunya virus strains. Clin. Infect. Dis., 2008, 47(3), 428-429. [http://dx.doi.org/10.1086/589925]. [PMID: 18605910].
[47]
Paupy, C.; Ollomo, B.; Kamgang, B.; Moutailler, S.; Rousset, D.; Demanou, M.; Hervé, J.P.; Leroy, E.; Simard, F. Comparative role of Aedes albopictus and Aedes aegypti in the emergence of Dengue and Chikungunya in central Africa. Vector Borne Zoonotic Dis., 2010, 10(3), 259-266. [http://dx.doi.org/10.1089/vbz.2009.0005]. [PMID: 19725769].
[48]
Vazeille, M.; Moutailler, S.; Coudrier, D.; Rousseaux, C.; Khun, H.; Huerre, M.; Thiria, J.; Dehecq, J.S.; Fontenille, D.; Schuffenecker, I.; Despres, P.; Failloux, A.B. Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus. PLoS One, 2007, 2(11)e1168 [http://dx.doi.org/10.1371/journal.pone.0001168]. [PMID: 18000540].
[49]
Borgherini, G.; Poubeau, P.; Staikowsky, F.; Lory, M.; Le Moullec, N.; Becquart, J.P.; Wengling, C.; Michault, A.; Paganin, F. Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin. Infect. Dis., 2007, 44(11), 1401-1407. [http://dx.doi.org/10.1086/517537]. [PMID: 17479933].
[50]
Kumar, N.P.; Suresh, A.; Vanamail, P.; Sabesan, S.; Krishnamoorthy, K.G.; Mathew, J.; Jose, V.T.; Jambulingam, P. Chikungunya virus outbreak in Kerala, India, 2007: a seroprevalence study. Mem. Inst. Oswaldo Cruz, 2011, 106(8), 912-916. [http://dx.doi.org/10.1590/S0074-02762011000800003]. [PMID: 22241110].
[51]
Wu, D.; Zhang, Y.; Zhouhui, Q.; Kou, J.; Liang, W.; Zhang, H.; Monagin, C.; Zhang, Q.; Li, W.; Zhong, H.; He, J.; Li, H.; Cai, S.; Ke, C.; Lin, J. Chikungunya virus with E1-A226V mutation causing two outbreaks in 2010, Guangdong, China. Virol. J., 2013, 10, 174. [http://dx.doi.org/10.1186/1743-422X-10-174]. [PMID: 23725047].
[52]
Chretien, J.P.; Fukuda, M.; Noedl, H. Improving surveillance for antimalarial drug resistance. JAMA, 2007, 297(20), 2278-2281. [http://dx.doi.org/10.1001/jama.297.20.2278]. [PMID: 17522014].
[53]
Srikanth, P.; Sarangan, G.; Mallilankaraman, K.; Nayar, S.A.; Barani, R.; Mattew, T.; Selvaraj, G.F.; Sheriff, K.A.; Palani, G.; Muthumani, K. Molecular characterization of Chikungunya virus during an outbreak in South India. Indian J. Med. Microbiol., 2010, 28(4), 299-302. [http://dx.doi.org/10.4103/0255-0857.71812]. [PMID: 20966558].
[54]
Apandi, Y.; Lau, S.K.; Izmawati, N.; Amal, N.M.; Faudzi, Y.; Mansor, W.; Hani, M.H.; Zainah, S. Identification of Chikungunya virus strains circulating in Kelantan, Malaysia in 2009. Southeast Asian J. Trop. Med. Public Health, 2010, 41(6), 1374-1380. [PMID: 21329313].
[55]
Rianthavorn, P.; Prianantathavorn, K.; Wuttirattanakowit, N.; Theamboonlers, A.; Poovorawan, Y. An outbreak of chikungunya in southern Thailand from 2008 to 2009 caused by African strains with A226V mutation. Int. J. Infect. Dis., 2010, 14(Suppl. 3), e161-e165. [http://dx.doi.org/10.1016/j.ijid.2010.01.001]. [PMID: 20417142].
[56]
Lanciotti, R.S.; Valadere, A.M. Transcontinental movement of Asian genotype chikungunya virus. Emerg. Infect. Dis., 2014, 20(8), 1400-1402. [http://dx.doi.org/10.3201/eid2008.140268]. [PMID: 25076384].
[57]
Leparc-Goffart, I.; Nougairede, A.; Cassadou, S.; Prat, C.; de Lamballerie, X. Chikungunya in the Americas. Lancet, 2014, 383(9916), 514. [http://dx.doi.org/10.1016/S0140-6736(14)60185-9]. [PMID: 24506907].
[58]
Staples, J.E.; Breiman, R.F.; Powers, A.M. Chikungunya fever: An epidemiological review of a re-emerging infectious disease. Clin. Infect. Dis., 2009, 49(6), 942-948. [http://dx.doi.org/10.1086/605496]. [PMID: 19663604].
[59]
Khan, M.; Santhosh, S.R.; Tiwari, M.; Lakshmana Rao, P.V.; Parida, M. Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in vero cells. J. Med. Virol., 2010, 82(5), 817-824. [http://dx.doi.org/10.1002/jmv.21663]. [PMID: 20336760].
[60]
Ravichandran, R.; Manian, M. Ribavirin therapy for Chikungunya arthritis. J. Infect. Dev. Ctries., 2008, 2(2), 140-142. [http://dx.doi.org/10.3855/T2.2.140]. [PMID: 19738340].
[61]
Kaur, P.; Chu, J.J.; Chu, H. Chikungunya virus: An update on antiviral development and challenges. Drug Discov. Today, 2013, 18(19-20), 969-983. [http://dx.doi.org/10.1016/j.drudis.2013.05.002]. [PMID: 23684571].
[62]
de Lamballerie, X.; Leroy, E.; Charrel, R.N.; Ttsetsarkin, K.; Higgs, S.; Gould, E.A. Chikungunya virus adapts to tiger mosquito via evolutionary convergence: a sign of things to come? Virol. J., 2008, 5, 33. [http://dx.doi.org/10.1186/1743-422X-5-33]. [PMID: 18304328].
[63]
Ahola, T.; Karlin, D.G. Sequence analysis reveals a conserved extension in the capping enzyme of the alphavirus supergroup, and a homologous domain in nodaviruses. Biol. Direct, 2015, 10, 16. [http://dx.doi.org/10.1186/s13062-015-0050-0]. [PMID: 25886938].
[64]
Delang, L.; Li, C.; Tas, A.; Quérat, G.; Albulescu, I.C.; De Burghgraeve, T.; Guerrero, N.A.; Gigante, A.; Piorkowski, G.; Decroly, E.; Jochmans, D.; Canard, B.; Snijder, E.J.; Pérez-Pérez, M.J.; van Hemert, M.J.; Coutard, B.; Leyssen, P.; Neyts, J. The viral capping enzyme nsP1: A novel target for the inhibition of chikungunya virus infection. Sci. Rep., 2016, 6, 31819. [http://dx.doi.org/10.1038/srep31819]. [PMID: 27545976].
[65]
Brandler, S.; Ruffié, C.; Combredet, C.; Brault, J.B.; Najburg, V.; Prevost, M.C.; Habel, A.; Tauber, E.; Desprès, P.; Tangy, F. A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus. Vaccine, 2013, 31(36), 3718-3725. [http://dx.doi.org/10.1016/j.vaccine.2013.05.086]. [PMID: 23742993].
[66]
Ramsauer, K.; Schwameis, M.; Firbas, C.; Müllner, M.; Putnak, R.J.; Thomas, S.J.; Desprès, P.; Tauber, E.; Jilma, B.; Tangy, F. Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. Lancet Infect. Dis., 2015, 15(5), 519-527. [http://dx.doi.org/10.1016/S1473-3099(15)70043-5]. [PMID: 25739878].
[67]
National Institute of Allergy and Infectious Diseases, National Institutes of Health Clinical Center: Chikungunya Virus Vaccine Trial in Healthy Adults. In:ClinicalTrials.gov. ; , 2013.
[69]
Metz, S.W.; Martina, B.E.; van den Doel, P.; Geertsema, C.; Osterhaus, A.D.; Vlak, J.M.; Pijlman, G.P. Chikungunya virus-like particles are more immunogenic in a lethal AG129 mouse model compared to glycoprotein E1 or E2 subunits. Vaccine, 2013, 31(51), 6092-6096. [http://dx.doi.org/10.1016/j.vaccine.2013.09.045]. [PMID: 24099875].
[70]
Akahata, W.; Yang, Z.Y.; Andersen, H.; Sun, S.; Holdaway, H.A.; Kong, W.P.; Lewis, M.G.; Higgs, S.; Rossmann, M.G.; Rao, S.; Nabel, G.J. A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat. Med., 2010, 16(3), 334-338. [http://dx.doi.org/10.1038/nm.2105]. [PMID: 20111039].
[71]
Metz, S.W.; Gardner, J.; Geertsema, C.; Le, T.T.; Goh, L.; Vlak, J.M.; Suhrbier, A.; Pijlman, G.P. Effective chikungunya virus-like particle vaccine produced in insect cells. PLoS Negl. Trop. Dis., 2013, 7(3)e2124 [http://dx.doi.org/10.1371/journal.pntd.0002124]. [PMID: 23516657].
[73]
Tripp, R.A.; Ross, T.M. Development of a Zika vaccine. Expert Rev. Vaccines, 2016, 15(9), 1083-1085. [http://dx.doi.org/10.1080/14760584.2016.1192474]. [PMID: 27212079].
[74]
Lagunas-Rangel, F.A.; Viveros-Sandoval, M.E.; Reyes-Sandoval, A. Current trends in Zika vaccine development. J. Virus Erad., 2017, 3(3), 124-127. [PMID: 28758019].
[76]
Fernandez, E.; Diamond, M.S. Vaccination strategies against Zika virus. Curr. Opin. Virol., 2017, 23, 59-67. [http://dx.doi.org/10.1016/j.coviro.2017.03.006]. [PMID: 28432975].
[77]
Wang, L.; Valderramos, S.G.; Wu, A.; Ouyang, S.; Li, C.; Brasil, P.; Bonaldo, M.; Coates, T.; Nielsen-Saines, K.; Jiang, T.; Aliyari, R.; Cheng, G. From mosquitos to humans: Genetic evolution of zika virus. Cell Host Microbe, 2016, 19(5), 561-565. [http://dx.doi.org/10.1016/j.chom.2016.04.006]. [PMID: 27091703].
[78]
Abbink, P.; Stephenson, K.E.; Barouch, D.H. Zika virus vaccines. Nat. Rev. Microbiol., 2018, 16(10), 594-600. [http://dx.doi.org/10.1038/s41579-018-0039-7]. [PMID: 29921914].
[79]
Fernandez, E.; Diamond, M.S. Vaccination strategies against Zika virus. Curr. Opin. Virol., 2017, 23, 59-67. [http://dx.doi.org/10.1016/j.coviro.2017.03.006]. [PMID: 28432975].
[81]
Wilder-Smith, A.; Vannice, K.; Durbin, A.; Hombach, J.; Thomas, S.J.; Thevarjan, I.; Simmons, C.P. Zika vaccines and therapeutics: Landscape analysis and challenges ahead. BMC Med., 2018, 16(1), 84. [http://dx.doi.org/10.1186/s12916-018-1067-x]. [PMID: 29871628].
[83]
Dowd, K.A.; Ko, S.Y.; Morabito, K.M.; Yang, E.S.; Pelc, R.S.; DeMaso, C.R.; Castilho, L.R.; Abbink, P.; Boyd, M.; Nityanandam, R.; Gordon, D.N.; Gallagher, J.R.; Chen, X.; Todd, J.P.; Tsybovsky, Y.; Harris, A.; Huang, Y.S.; Higgs, S.; Vanlandingham, D.L.; Andersen, H.; Lewis, M.G.; De La Barrera, R.; Eckels, K.H.; Jarman, R.G.; Nason, M.C.; Barouch, D.H.; Roederer, M.; Kong, W.P.; Mascola, J.R.; Pierson, T.C.; Graham, B.S. Rapid development of a DNA vaccine for Zika virus. Science, 2016, 354(6309), 237-240. [http://dx.doi.org/10.1126/science.aai9137]. [PMID: 27708058].
[84]
Diehl, M.C.; Lee, J.C.; Daniels, S.E.; Tebas, P.; Khan, A.S.; Giffear, M.; Sardesai, N.Y.; Bagarazzi, M.L. Tolerability of intramuscular and intradermal delivery by CELLECTRA(®) adaptive constant current electroporation device in healthy volunteers. Hum. Vaccin. Immunother., 2013, 9(10), 2246-2252. [http://dx.doi.org/10.4161/hv.24702]. [PMID: 24051434].
[85]
Abbink, P.; Larocca, R.A.; De La Barrera, R.A.; Bricault, C.A.; Moseley, E.T.; Boyd, M.; Kirilova, M.; Li, Z.; Ng’ang’a, D.; Nanayakkara, O.; Nityanandam, R.; Mercado, N.B.; Borducchi, E.N.; Agarwal, A.; Brinkman, A.L.; Cabral, C.; Chandrashekar, A.; Giglio, P.B.; Jetton, D.; Jimenez, J.; Lee, B.C.; Mojta, S.; Molloy, K.; Shetty, M.; Neubauer, G.H.; Stephenson, K.E.; Peron, J.P.S.; Zanotto, P.M.D.; Misamore, J.; Finneyfrock, B.; Lewis, M.G.; Alter, G.; Modjarrad, K.; Jarman, R.G.; Eckels, K.H.; Michael, N.L.; Thomas, S.J.; Barouch, D.H. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science, 2016, 353(6304), 1129-1132. [http://dx.doi.org/10.1126/science.aah6157]. [PMID: 27492477].
[86]
Pardi, N.; Hogan, M.J.; Pelc, R.S.; Muramatsu, H.; Andersen, H.; DeMaso, C.R.; Dowd, K.A.; Sutherland, L.L.; Scearce, R.M.; Parks, R.; Wagner, W.; Granados, A.; Greenhouse, J.; Walker, M.; Willis, E.; Yu, J.S.; McGee, C.E.; Sempowski, G.D.; Mui, B.L.; Tam, Y.K.; Huang, Y.J.; Vanlandingham, D.; Holmes, V.M.; Balachandran, H.; Sahu, S.; Lifton, M.; Higgs, S.; Hensley, S.E.; Madden, T.D.; Hope, M.J.; Karikó, K.; Santra, S.; Graham, B.S.; Lewis, M.G.; Pierson, T.C.; Haynes, B.F.; Weissman, D. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature, 2017, 543(7644), 248-251. [http://dx.doi.org/10.1038/nature21428]. [PMID: 28151488].
[88]
Fernandez, E.; Diamond, M.S. Vaccination strategies against Zika virus. Curr. Opin. Virol., 2017, 23, 59-67. [http://dx.doi.org/10.1016/j.coviro.2017.03.006]. [PMID: 28432975].
[89]
Halstead, S.B. Biologic evidence required for Zika disease enhancement by Dengue antibodies. Emerg. Infect. Dis., 2017, 23(4), 569-573. [http://dx.doi.org/10.3201/eid2304.161879]. [PMID: 28322690].
[90]
Domingos, A.; Antunes, S.; Borges, L.; Rosário, V.E. Approaches towards tick and tick-borne diseases control. Rev. Soc. Bras. Med. Trop., 2013, 46(3), 265-269. [http://dx.doi.org/10.1590/0037-8682-0014-2012]. [PMID: 23559344].
[91]
Dantas-Torres, F.; Chomel, B.B.; Otranto, D. Ticks and tick-borne diseases: A One Health perspective. Trends Parasitol., 2012, 28(10), 437-446. [http://dx.doi.org/10.1016/j.pt.2012.07.003]. [PMID: 22902521].
[92]
Martins, J.R.; Corrêa, B.L.; Ceresér, V.H.; Arteche, C.C.P. 1995.
[93]
Tavassoli, M.; Malekifard, F.; Soleimanzadeh, A.; Pourseyed, S.H.; Bernousi, I.; Mardani, K. Susceptibility of different life stages of Ornithodoros lahorensis to entomopathogenic fungi Metarhizium anisopliae and Beauveria bassiana. Parasitol. Res., 2012, 111(4), 1779-1783. [http://dx.doi.org/10.1007/s00436-012-3023-6]. [PMID: 22782474].
[94]
Šmit, R.; Postma, M.J. Vaccines for tick-borne diseases and cost-effectiveness of vaccination: A public health challenge to reduce the diseases’ burden. Expert Rev. Vaccines, 2016, 15(1), 5-7. [http://dx.doi.org/10.1586/14760584.2016.1111142]. [PMID: 26559456].
[95]
Zent, O.; Bröker, M. Tick-borne encephalitis vaccines: Past and present. Expert Rev. Vaccines, 2005, 4(5), 747-755. [http://dx.doi.org/10.1586/14760584.4.5.747]. [PMID: 16221075].
[96]
Wressnigg, N.; Pöllabauer, E.M.; Aichinger, G.; Portsmouth, D.; Löw-Baselli, A.; Fritsch, S.; Livey, I.; Crowe, B.A.; Schwendinger, M.; Brühl, P.; Pilz, A.; Dvorak, T.; Singer, J.; Firth, C.; Luft, B.; Schmitt, B.; Zeitlinger, M.; Müller, M.; Kollaritsch, H.; Paulke-Korinek, M.; Esen, M.; Kremsner, P.G.; Ehrlich, H.J.; Barrett, P.N. Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: A double-blind, randomised, dose-escalation phase 1/2 trial. Lancet Infect. Dis., 2013, 13(8), 680-689. [http://dx.doi.org/10.1016/S1473-3099(13)70110-5]. [PMID: 23665341].
[97]
Valbuena, G.; Walker, D.H. Approaches to vaccines against Orientia tsutsugamushi. Front. Cell. Infect. Microbiol., 2013, 2, 170. [http://dx.doi.org/10.3389/fcimb.2012.00170]. [PMID: 23316486].
[98]
Jeong, Y.J.; Kim, S.; Wook, Y.D.; Lee, J.W.; Kim, K.I.; Lee, S.H. Scrub typhus: clinical, pathologic, and imaging findings. Radiographics, 2007, 27(1), 161-172. [http://dx.doi.org/10.1148/rg.271065074]. [PMID: 17235005].
[99]
Peter, J.V.; Sudarsan, T.I.; Prakash, J.A.J.; Varghese, G.M. Severe scrub typhus infection: Clinical features, diagnostic challenges and management. World J. Crit. Care Med., 2015, 4(3), 244-250. [http://dx.doi.org/10.5492/wjccm.v4.i3.244]. [PMID: 26261776].
[100]
Xu, G.; Walker, D.H.; Jupiter, D.; Melby, P.C.; Arcari, C.M. A review of the global epidemiology of scrub typhus. PLoS Negl. Trop. Dis., 2017, 11(11)e0006062
[101]
Chakraborty, S.; Sarma, N. Scrub typhus: An emerging threat. Indian J. Dermatol., 2017, 62(5), 478-485. [PMID: 28979009].
[102]
Bonell, A.; Lubell, Y.; Newton, P.N.; Crump, J.A.; Paris, D.H. Estimating the burden of scrub typhus: A systematic review. PLoS Negl. Trop. Dis., 2017, 11(9)e0005838 [http://dx.doi.org/10.1371/journal.pntd.0005838]. [PMID: 28945755].
[103]
Kelly, D.J.; Fuerst, P.A.; Ching, W.M.; Richards, A.L. Scrub typhus: the geographic distribution of phenotypic and genotypic variants of Orientia tsutsugamushi. Clin. Infect. Dis., 2009, 48(Suppl. 3), S203-S230. [http://dx.doi.org/10.1086/596576]. [PMID: 19220144].
[104]
Ha, N.Y.; Sharma, P.; Kim, G.; Kim, Y.; Min, C.K.; Choi, M.S.; Kim, I.S.; Cho, N.H. Immunization with an autotransporter protein of Orientia tsutsugamushi provides protective immunity against scrub typhus. PLoS Negl. Trop. Dis., 2015, 9(3)e0003585 [http://dx.doi.org/10.1371/journal.pntd.0003585]. [PMID: 25768004].
[105]
Lee, M.J.; Hung, S.H.; Huang, M.C.; Tsai, T.; Chen, C.T. Doxycycline potentiates antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy in malignant peripheral nerve sheath tumor cells. PLoS One, 2017, 12(5)e0178493 [http://dx.doi.org/10.1371/journal.pone.0178493]. [PMID: 28558025].
[106]
Fang, Y.; Huang, Z.; Tu, C.; Zhang, L.; Ye, D.; Zhu, B.P. Meta-analysis of drug treatment for scrub typhus in Asia. Intern. Med., 2012, 51(17), 2313-2320. [http://dx.doi.org/10.2169/internalmedicine.51.7816]. [PMID: 22975540].
[107]
Rajapakse, S.; Rodrigo, C.; Fernando, S.D. Drug treatment of scrub typhus. Trop. Doct., 2011, 41(1), 1-4. [http://dx.doi.org/10.1258/td.2010.100311]. [PMID: 21172901].
